Humoral Response to BNT162b2 mRNA SARS-CoV-2 Vaccine in Patients with Nondialysis Chronic Kidney Disease

Clin J Am Soc Nephrol. 2021 Dec;16(12):1872-1874. doi: 10.2215/CJN.09110721. Epub 2021 Nov 3.

Authors

Delphine Kervella^{1

2}, Pierre Braud¹, Claire Garandeau¹, Celine Phelizot¹, Xavier Ambrosi³, Gilles Blancho^{1

2}, Maryvonne Hourmant¹, Lucile Figueres; Divat Consortium

Affiliations

¹ Institut de Transplantation Urologie Néphrologie, Centre Hospitalo-Universitaire (CHU) Nantes, Nantes, France.
² Centre de Recherche en Transplantation et Immunologie, Unité Mixte de Recherche (UMR) 1064, Institut National de la Santé et de la Recherche Médicale, Université de Nantes, Nantes, France.
³ Service d'anesthésie réanimation, Centre Hospitalo-Universitaire (CHU) de Nantes, Nantes, France.

No abstract available

Keywords: COVID-19; SARS-CoV-2; chronic kidney disease; vaccine.

Publication types

Letter

MeSH terms

BNT162 Vaccine
COVID-19 Vaccines*
COVID-19* / prevention & control
Humans
Immunity, Humoral
Patients
SARS-CoV-2

Substances

COVID-19 Vaccines
BNT162 Vaccine